Overview

Combination Therapy Prevents the Relapse of RA

Status:
Recruiting
Trial end date:
2020-09-01
Target enrollment:
Participant gender:
Summary
This trial aims to compare the cost effective and effect of preventing recurrence by different treatment of TFP and HCQ combined SSZ for remittent RA.
Phase:
N/A
Details
Lead Sponsor:
Peking University First Hospital
Collaborators:
Beijing Hospital
Beijing Jishuitan Hospital
Beijing Shijitan Hospital
Beijing Shijitan Hospital, Capital Medical University
Peking University People's Hospital
Peking University Shougang Hospital
Peking University Third Hospital